MLSS Milestone Scientific Inc
Price (delayed)
$1.01
Market cap
$78.67M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.07
Enterprise value
$74.21M
Milestone Scientific Inc. is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary
Highlights
The net income has grown by 34% year-on-year
The debt has contracted by 26% YoY and by 8% from the previous quarter
The revenue is down by 9% year-on-year but it is up by 5% since the previous quarter
The company's quick ratio fell by 11% QoQ and by 11% YoY
The equity has contracted by 9% from the previous quarter
Key stats
What are the main financial stats of MLSS
Market
Valuations
Earnings
Shares outstanding
77.89M
Market cap
$78.67M
Enterprise value
$74.21M
Price to earnings (P/E)
N/A
Price to book (P/B)
10.81
Price to sales (P/S)
9.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.36
Revenue
$8.88M
Gross profit
$6.43M
Operating income
-$6.69M
Net income
-$4.62M
EBIT
-$4.76M
EBITDA
-$4.63M
Free cash flow
-$2.66M
Per share
Balance sheet
Liquidity
EPS
-$0.07
EPS diluted
-$0.07
Free cash flow per share
-$0.03
Book value per share
$0.09
Revenue per share
$0.11
TBVPS
$0.14
Total assets
$11.17M
Total liabilities
$3.95M
Debt
$311,692
Equity
$7.22M
Working capital
$6.94M
Debt to equity
0.04
Current ratio
2.85
Quick ratio
1.42
Net debt/EBITDA
0.96
Margins
Efficiency
Dividend
EBITDA margin
-52.1%
Gross margin
72.5%
Net margin
-52%
Operating margin
-75.4%
Return on assets
-40.2%
Return on equity
-60.3%
Return on invested capital
-128.2%
Return on capital employed
-64.2%
Return on sales
-53.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MLSS stock price
How has the Milestone Scientific stock price performed over time
Intraday
6.32%
1 week
0%
1 month
7.46%
1 year
59.16%
YTD
5.21%
QTD
8.3%
Financial performance
How have Milestone Scientific's revenue and profit performed over time
Revenue
$8.88M
Gross profit
$6.43M
Operating income
-$6.69M
Net income
-$4.62M
Gross margin
72.5%
Net margin
-52%
The net income has grown by 34% year-on-year
The net margin has grown by 27% YoY and by 5% from the previous quarter
The company's gross margin rose by 12% YoY
The revenue is down by 9% year-on-year but it is up by 5% since the previous quarter
Growth
What is Milestone Scientific's growth rate over time
Valuation
What is Milestone Scientific stock price valuation
P/E
N/A
P/B
10.81
P/S
9.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
8.36
Milestone Scientific's EPS has increased by 22% YoY
The P/B is 41% higher than the last 4 quarters average of 7.2 and 39% higher than the 5-year quarterly average of 7.3
The equity has contracted by 9% from the previous quarter
The P/S is 36% more than the last 4 quarters average of 6.3 but 28% less than the 5-year quarterly average of 11.9
The revenue is down by 9% year-on-year but it is up by 5% since the previous quarter
Efficiency
How efficient is Milestone Scientific business performance
MLSS's ROA is up by 31% YoY
Milestone Scientific's ROS has increased by 26% YoY and by 5% from the previous quarter
The return on equity has increased by 24% year-on-year
The company's return on invested capital fell by 17% QoQ but it rose by 12% YoY
Dividends
What is MLSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MLSS.
Financial health
How did Milestone Scientific financials performed over time
The total assets is 183% greater than the total liabilities
The company's quick ratio fell by 11% QoQ and by 11% YoY
The total liabilities has increased by 10% year-on-year but it has declined by 2.4% since the previous quarter
The debt is 96% less than the equity
Milestone Scientific's debt to equity has decreased by 33% YoY
The debt has contracted by 26% YoY and by 8% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.